Hester Bios

{
  "main_header": {
    "sid": 324228,
    "name": "Hester Bios",
    "stock_name": "Hester Bios",
    "full_name": "Hester Biosciences Ltd",
    "name_url": "stocks-analysis/hester-bios",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,867.45",
    "chg": -12.45,
    "chgp": "-0.66%",
    "dir": -1,
    "prev_price": "1,879.90",
    "mcapval": "1,607.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524669,
    "symbol": "HESTERBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE782E01017",
    "curr_date": "May 22",
    "curr_time": "",
    "bse_nse_vol": "18.51 k",
    "exc_status": "Active",
    "traded_date": "May 22, 2026",
    "traded_date_str": "2026 05 22",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hester-bios-324228-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Hester Biosciences Gains 1.82%: 7 Key Factors Driving the Week’s Mixed Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-gains-182-7-key-factors-driving-the-weeks-mixed-momentum-4009108",
        "imagepath": "",
        "date": "2026-05-24 10:00:50",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>18 May:</strong> Mojo Grade upgraded to Hold on technical improvements and steady financials</p>\n                    <p><strong>19 May:</strong> Technical momentum shifts amid mixed market signals; stock dips 3.48%</p>\n                    <p><strong>20 May:</strong> Q4 FY26 results reveal profit surge but valuation concerns persist</p>\n                    <p><strong>21 May:</strong> Mojo Grade downgraded to Sell amid mixed financial and technical signals</p>\n                    <p><strong>22 May:</strong> Technical momentum shifts to mildly bullish; stock closes at Rs.1,879.90 (+2.18%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div cla..."
      },
      {
        "title": "Hester Biosciences Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-sees-technical-momentum-shift-amid-mixed-indicator-signals-4004242",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/HesterBioscienc_technicaldot_4004242.png",
        "date": "2026-05-22 08:00:57",
        "description": "Hester Biosciences Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s price action and technical indicators reveal a complex interplay of bullish and bearish signals, warranting a detailed analysis for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Hester Biosciences Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-downgraded-to-sell-amid-mixed-financial-and-technical-signals-4002279",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/HesterBioscienc_mojoScore_4002279.png",
        "date": "2026-05-21 08:12:43",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 20 May 2026. This shift reflects a complex interplay of technical indicators, valuation metrics, financial trends, and quality assessments that collectively signal caution for investors despite recent positive earnings momentum."
      },
      {
        "title": "Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-4002053",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/HesterBioscienc_technicaldot_4002053.png",
        "date": "2026-05-21 08:00:56",
        "description": "Hester Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. Despite a recent 2.40% gain in the stock price to ₹1,839.85, the company’s overall technical outlook remains mixed, with divergent signals from MACD, RSI, moving averages, and other momentum oscillators."
      },
      {
        "title": "Are Hester Biosciences Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-hester-biosciences-ltd-latest-results-good-or-bad-4001466",
        "imagepath": "",
        "date": "2026-05-20 19:20:25",
        "description": "Hester Biosciences Ltd's latest financial results for Q4 FY26 indicate a notable operational turnaround compared to the previous year. The company reported a consolidated net profit of ₹15.98 crores, reflecting a significant year-on-year growth of 1,138.76%, a stark contrast to the near-zero profitability recorded in the same quarter last year. Additionally, revenue reached ₹100.11 crores, marking a year-on-year increase of 22.19% and surpassing previous quarterly records.\n\nThe operating margin for this quarter stood at 34.29%, which is the highest in the company's history, showcasing substantial margin expansion driven by improved operational efficiencies and cost management. This margin represents a significant improvement from the prior year's figures, indicating a strong recovery in profitability.\n\nSequentially, the results also demonstrate positive momentum, with net profit increasing by 82.21% from ₹8..."
      },
      {
        "title": "Hester Biosciences Q4 FY26: Profit Surge Masks Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/hester-biosciences-q4-fy26-profit-surge-masks-valuation-concerns-3999593",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/HesterBioscienc_quaterlyResult_3999593.png",
        "date": "2026-05-19 21:01:12",
        "description": "Hester Biosciences Limited, one of India's pioneering animal healthcare companies, delivered a remarkable turnaround in Q4 FY26 with consolidated net profit surging 1,138.76% year-on-year to ₹15.98 crores, recovering from the previous year's dismal ₹1.29 crores. The Ahmedabad-based vaccine manufacturer also posted its highest-ever quarterly revenue of ₹100.11 crores, marking a 22.19% YoY growth, whilst operating margins expanded significantly to 34.29%. However, the stock's muted response—trading at ₹1,796.75 with a modest 1.49% gain following the results—reflects investor concerns about stretched valuations and inconsistent historical performance."
      },
      {
        "title": "Hester Biosciences Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-3997816",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/HesterBioscienc_technicaldot_3997816.png",
        "date": "2026-05-19 08:01:47",
        "description": "Hester Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend as of mid-May 2026. Despite a recent downgrade in technical trend sentiment, the stock’s mixed signals across key indicators such as MACD, RSI, Bollinger Bands, and moving averages suggest a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Hester Biosciences Ltd Upgraded to Hold on Technical Improvements and Steady Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-upgraded-to-hold-on-technical-improvements-and-steady-financials-3996238",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/HesterBioscienc_mojoScore_3996238.png",
        "date": "2026-05-18 08:07:11",
        "description": "Hester Biosciences Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a shift in technical indicators and a stabilisation in financial performance. The upgrade, effective from 15 May 2026, is driven primarily by improved technical trends, steady financial results, and a more balanced valuation outlook amid mixed long-term growth prospects."
      },
      {
        "title": "Hester Biosciences Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-sees-technical-momentum-shift-amid-mixed-indicator-signals-3995877",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/HesterBioscienc_technicaldot_3995877.png",
        "date": "2026-05-18 08:00:43",
        "description": "Hester Biosciences Ltd has exhibited a notable shift in price momentum, transitioning from a sideways trend to a mildly bullish stance, supported by a complex interplay of technical indicators. Despite mixed signals from key oscillators and moving averages, the stock’s recent performance and technical upgrades suggest cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 5465,
    "sid": "324228",
    "stock_news_url": "https://www.marketsmojo.com/news/hester-biosciences-324228"
  },
  "announcements": [
    {
      "caption": "Announcement Under Regulation 30 Of Listing Regulations - Disclosure On Amendments In Loan Agreement Of Hester Africa",
      "datetime": "20-May-2026",
      "details": "Announcement under Regulation 30 of Listing Regulation - Amendments in Loan agreement of Hester Africa",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Submission Of The Reclassification Application Under Regulation 31A Of Listing Regulations",
      "datetime": "20-May-2026",
      "details": "Intimation of Submission of reclassification application with the stock exchanges under Regulations 31A of Listing Regulations",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "18-May-2026",
      "details": "Annual Secretarial Compliance Report for the year ended 31 March 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has declared <strong>70%</strong> dividend, ex-date: 06 Aug 25",
          "dt": "2025-08-06",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 27 Sep 12",
          "dt": "2012-09-27",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>2:5</strong> rights issue, ex-date: 29 May 06",
          "dt": "2006-05-29",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Hester Biosciences Gains 1.82%: 7 Key Factors Driving the Week’s Mixed Momentum

2026-05-24 10:00:50

Key Events This Week

18 May: Mojo Grade upgraded to Hold on technical improvements and steady financials

19 May: Technical momentum shifts amid mixed market signals; stock dips 3.48%

20 May: Q4 FY26 results reveal profit surge but valuation concerns persist

21 May: Mojo Grade downgraded to Sell amid mixed financial and technical signals

22 May: Technical momentum shifts to mildly bullish; stock closes at Rs.1,879.90 (+2.18%)

Read full news article

Hester Biosciences Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals

2026-05-22 08:00:57

Hester Biosciences Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s price action and technical indicators reveal a complex interplay of bullish and bearish signals, warranting a detailed analysis for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Hester Biosciences Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-05-21 08:12:43

Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 20 May 2026. This shift reflects a complex interplay of technical indicators, valuation metrics, financial trends, and quality assessments that collectively signal caution for investors despite recent positive earnings momentum.

Read full news article

Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-21 08:00:56

Hester Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. Despite a recent 2.40% gain in the stock price to ₹1,839.85, the company’s overall technical outlook remains mixed, with divergent signals from MACD, RSI, moving averages, and other momentum oscillators.

Read full news article

Are Hester Biosciences Ltd latest results good or bad?

2026-05-20 19:20:25

Hester Biosciences Ltd's latest financial results for Q4 FY26 indicate a notable operational turnaround compared to the previous year. The company reported a consolidated net profit of ₹15.98 crores, reflecting a significant year-on-year growth of 1,138.76%, a stark contrast to the near-zero profitability recorded in the same quarter last year. Additionally, revenue reached ₹100.11 crores, marking a year-on-year increase of 22.19% and surpassing previous quarterly records. The operating margin for this quarter stood at 34.29%, which is the highest in the company's history, showcasing substantial margin expansion driven by improved operational efficiencies and cost management. This margin represents a significant improvement from the prior year's figures, indicating a strong recovery in profitability. Sequentially, the results also demonstrate positive momentum, with net profit increasing by 82.21% from ₹8...

Read full news article

Hester Biosciences Q4 FY26: Profit Surge Masks Valuation Concerns

2026-05-19 21:01:12

Hester Biosciences Limited, one of India's pioneering animal healthcare companies, delivered a remarkable turnaround in Q4 FY26 with consolidated net profit surging 1,138.76% year-on-year to ₹15.98 crores, recovering from the previous year's dismal ₹1.29 crores. The Ahmedabad-based vaccine manufacturer also posted its highest-ever quarterly revenue of ₹100.11 crores, marking a 22.19% YoY growth, whilst operating margins expanded significantly to 34.29%. However, the stock's muted response—trading at ₹1,796.75 with a modest 1.49% gain following the results—reflects investor concerns about stretched valuations and inconsistent historical performance.

Read full news article

Hester Biosciences Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-05-19 08:01:47

Hester Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend as of mid-May 2026. Despite a recent downgrade in technical trend sentiment, the stock’s mixed signals across key indicators such as MACD, RSI, Bollinger Bands, and moving averages suggest a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Hester Biosciences Ltd Upgraded to Hold on Technical Improvements and Steady Financials

2026-05-18 08:07:11

Hester Biosciences Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a shift in technical indicators and a stabilisation in financial performance. The upgrade, effective from 15 May 2026, is driven primarily by improved technical trends, steady financial results, and a more balanced valuation outlook amid mixed long-term growth prospects.

Read full news article

Hester Biosciences Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals

2026-05-18 08:00:43

Hester Biosciences Ltd has exhibited a notable shift in price momentum, transitioning from a sideways trend to a mildly bullish stance, supported by a complex interplay of technical indicators. Despite mixed signals from key oscillators and moving averages, the stock’s recent performance and technical upgrades suggest cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

View All News